Mesalazine as a cause of fetal anemia and hydrops fetalis: A case report.

Author: EkSverker, RosenborgStaffan

Paper Details 
Original Abstract of the Article :
Mesalazine and its prodrug sulfasalazine are both used for inflammatory bowel disease. Sulfasalazine has been associated with hematological side-effects such as aplastic and hemolytic anemia in patients, but also in fetuses after intrauterine exposure. To our knowledge, we describe the first case of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815793/

データ提供:米国国立医学図書館(NLM)

Mesalazine and Fetal Anemia: A Case of Drug-Induced Complications

This [case report] delves into the potential complications associated with the use of mesalazine, a medication commonly used to treat [inflammatory bowel disease], during pregnancy. The researchers documented a rare case of a fetus with severe anemia and hydrops fetalis, a condition characterized by fluid accumulation in the body, potentially linked to maternal exposure to mesalazine. The case report raises concerns about the potential risks of mesalazine during pregnancy and underscores the need for careful monitoring of pregnant women taking this medication.

Mesalazine and Pregnancy: Navigating the Risks

The case report provides a stark reminder of the potential risks associated with certain medications during pregnancy. While mesalazine is generally considered safe for pregnant women, this case highlights the possibility of rare but serious side effects. The report underscores the importance of close monitoring of pregnant women taking mesalazine, as well as careful consideration of the potential benefits and risks of this medication in each individual case.

Navigating Pregnancy: A Balancing Act of Health and Safety

Pregnancy is a time of profound physical and emotional change, and navigating the complexities of this period requires careful attention to health and safety. Just as a desert camel carefully chooses its path through the arid landscape, pregnant women must prioritize their own health and the well-being of their developing child. The case report reminds us that even commonly used medications can have unexpected consequences during pregnancy, highlighting the importance of open communication with healthcare providers and a proactive approach to managing health risks.

Dr. Camel's Conclusion

This case report serves as a reminder that even seemingly safe medications can pose unexpected risks during pregnancy. Just as the desert camel faces challenges navigating its harsh environment, pregnant women must be aware of potential risks and seek appropriate medical care to ensure a healthy pregnancy and a safe journey towards motherhood.

Date :
  1. Date Completed 2018-02-12
  2. Date Revised 2022-10-05
Further Info :

Pubmed ID

29390381

DOI: Digital Object Identifier

PMC5815793

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.